Serum Institute of India

Serum Institute of India Private Limited
Company typePrivate
Industry
Founded1966; 58 years ago (1966)
FounderCyrus S. Poonawalla (Chairman & MD)
HeadquartersPune, Maharashtra, India
Area served
Worldwide
Key people
Adar Poonawalla (CEO)
Products
RevenueIncrease ₹25,646 crore (US$3.1 billion) (FY22)[1]
Increase ₹17,562 crore (US$2.1 billion) (FY22)[1]
Increase ₹11,116 crore (US$1.3 billion) (FY22)[1]
ParentCyrus Poonawalla Group
SubsidiariesBilthoven Biologicals BV[2]
Vakzine Projekt Management GmbH[3]
Websitewww.seruminstitute.com Edit this at Wikidata

18°30′18″N 73°56′44″E / 18.505110°N 73.945453°E / 18.505110; 73.945453 Serum Institute of India (SII) is an Indian multinational biotechnology and biopharmaceuticals company, based in Pune.[4] It is the world's largest manufacturer of vaccines by volume.[5][6][7] It was founded by Cyrus Poonawalla in 1966[5] and is a part of Cyrus Poonawalla Group.[8]

  1. ^ a b c "Serum Institute of India Private Limited" (PDF). CARE Ratings. Retrieved 3 February 2023.
  2. ^ "Bilthoven Biologicals acquired by Serum Institute of India". www.thepharmaletter.com. Retrieved 10 July 2020.
  3. ^ "Profile". vpm-consult.com. Retrieved 10 July 2020.
  4. ^ "Serum Institute of India Pvt. Ltd.: Private Company Information". bloomberg.com. Retrieved 30 September 2018.
  5. ^ a b Cite error: The named reference cnbc was invoked but never defined (see the help page).
  6. ^ Cite error: The named reference dw was invoked but never defined (see the help page).
  7. ^ Kalra, Aditya (24 May 2022). "Indian vaccine giant Serum plans African plant in global expansion". Reuters. Retrieved 15 September 2024.
  8. ^ "Poonawalla Investments AND Industries Private Limited Information - Poonawalla Investments AND Industries Private Limited Company Profile, Poonawalla Investments AND Industries Private Limited News on The Economic Times". The Economic Times. Archived from the original on 8 May 2019. Retrieved 10 July 2020.